Resources
Brochure
Case Study
Case Study
White Paper
Citeline Report - Executing Early Phase Research In Hematological Oncology: What Matters To Biotech?
Blog
The Black Box of Anti-COVID-19 Monoclonal Antibodies: An Overview, Definitions, and Terminology
Blog
Expediting Treatments to Oncology Patients in Need: Understanding the FDA’s Accelerated Pathways
Presentation
Managing Clinical Trial Risk Strategically: Collaborating for Success With Your Outsourcing Partners
White Paper
Webinar
Pre-Anticipation: Anticipating Obstacles to Approval Before Phase I in Oncology Drug Development
Blog
Multicenter Phase III Study Efficacy of mAb Treatment for Ventilator-Associated Pneumonia (VAP)
Webinar
Enrollment, Enrichment, and Monitoring Strategies to Accelerate Phase 3 Clinical Trials in NASH
Blog
Poster
Overview of immuno-oncology clinical trial conduct and design investigating combination therapies
Blog
Draft Guidance of the Formal Meetings Between the FDA and Sponsors or Applicants of BsUFA Products
White Paper
Blog
New Meeting Opportunities with FDA through the Model-Informed Drug Development (MIDD) Pilot Program
White Paper